UK Biobank Tender for Whole Genome Sequencing

UK Biobank Tender for Whole Genome Sequencing

UK Biobank requires a single sequencing provider that can offer Whole Genome Sequencing services that meet the requirements outlined in the specification.

United Kingdom-Stockport: Medical analysis services

2018/S 020-041805

Contract notice

Services

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

UK Biobank Ltd
1-2 Spectrum Way, Adswood
Stockport
SK3 0SA
United Kingdom
Contact person: Andrea Howard
Telephone: +44 1614755386
E-mail: tenders@ukbiobank.ac.uk
NUTS code: UKD35
Internet address(es):Main address: http://www.ukbiobank.ac.uk

Address of the buyer profile: https://www.mytenders.co.uk/search/Search_AuthProfile.aspx?ID=AA25607

I.2)Joint procurement

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: https://www.mytenders.co.uk/search/Search_AuthProfile.aspx?ID=AA25607
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://www.mytenders.co.uk/search/Search_AuthProfile.aspx?ID=AA25607

I.4)Type of the contracting authority

Body governed by public law

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

Whole Genome Sequencing

Reference number: UKBB005

II.1.2)Main CPV code

85148000

II.1.3)Type of contract

Services

II.1.4)Short description:

UK Biobank requires a single sequencing provider that can offer Whole Genome Sequencing (WGS) services that meet the requirements outlined in the specification.

The key parameters for any bidder are as follows:

— There is up to GBP 30m funding available for the conduct of a vanguard phase of whole genome sequencing,

— The scope of the tender is for sequencing (and certain named ancillary) services only,

— The sequencing for this vanguard phase should ideally be completed by the end of 2019.

II.1.5)Estimated total value

Value excluding VAT: 30 000 000.00 GBP

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)

II.2.3)Place of performance

NUTS code: UKD3

II.2.4)Description of the procurement:

This procurement is being conducted under regulation 74 of the Public Contracts Regulations 2015 (as amended) as a light touch procedure, although we are voluntarily adopting a process akin to the open procedure. UK Biobank is issuing this tender to invite bids to conduct a vanguard phase of whole genome sequencing. The principal purpose of this vanguard phase is to inform and develop the protocols and processes for the whole genome sequencing of all UK Biobank’s 500 000 participants which is expected to take place (subject to confirmation of funding) in the next few years.

UK Biobank is a major national health resource, and a registered charity in its own right, with the aim of improving the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses – including cancer, heart diseases, stroke, diabetes, arthritis, osteoporosis, eye disorders, depression and forms of dementia.

UK Biobank recruited 500 000 people aged between 40-69 years in 2006-2010 from across the country to take part in this project. They have undergone measures, provided blood, urine and saliva samples for future analysis, given detailed information about themselves and agreed to have their health followed. Over many years this will build into a powerful resource to help scientists discover why some people develop particular diseases and others do not.

II.2.5)Award criteria

Criteria below
Quality criterion – Name: Technical Requirements / Weighting: 65 %
Quality criterion – Name: Scale / Weighting: 5 %
Quality criterion – Name: Collaboration / Weighting: 20 %
Price – Weighting: 10 %

II.2.6)Estimated value

Value excluding VAT: 30 000 000.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36
This contract is subject to renewal: yes
Description of renewals:

There may be the need to extend the duration based upon outcomes from the vanguard phase.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: no
II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

III.1.2)Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3)Technical and professional ability

Selection criteria as stated in the procurement documents
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.1)Information about a particular profession
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 27/02/2018
Local time: 09:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English
IV.2.6)Minimum time frame during which the tenderer must maintain the tender

IV.2.7)Conditions for opening of tenders

Date: 27/02/2018
Local time: 12:00

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no

VI.2)Information about electronic workflows

Electronic invoicing will be accepted
Electronic payment will be used

VI.3)Additional information:

NOTE: To register your interest in this notice and obtain any additional information please visit the myTenders Web Site at http://www.myTenders.org/Search/Search_Switch.aspx?ID=206350

The buyer has indicated that it will accept electronic responses to this notice via the Postbox facility. A user guide is available at http://www.myTenders.org/sitehelp/help_guides.aspx

Suppliers are advised to allow adequate time for uploading documents and to dispatch the electronic response well in advance of the closing time to avoid any last minute problems.

(MT Ref:206350).

VI.4)Procedures for review

VI.4.1)Review body

UK Biobank Ltd
1-2 Spectrum Way, Adswood
Stockport
SK3 0SA
United Kingdom
Telephone: +44 1614755386Internet address:http://www.ukbiobank.ac.uk
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

26/01/2018

 

Read More

Genomic Testing Services Tender

Radon Testing Contract

Public Health Microbiology Services Tender

Managed Laboratory Service Contract for Pathology

Pathology Managed Laboratory Services Contract Newport